64715-86-2 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-1-phenyl-2-methoxyethylamine hydrochloride is used as a key intermediate in the pharmaceutical industry for the synthesis of various medications. Its role in creating new drugs is significant due to its versatile chemical properties and reactivity.
Used in Neurodegenerative Disorder Treatment:
In the medical field, (S)-1-phenyl-2-methoxyethylamine hydrochloride is used as a potential therapeutic agent for treating neurodegenerative disorders. Its ability to modulate neurotransmitters makes it a promising candidate for developing treatments that can slow down or halt the progression of these conditions.
Used in Mood Disorder Treatment:
(S)-1-phenyl-2-methoxyethylamine hydrochloride is used as a selective serotonin releaser and reuptake inhibitor, making it a potential candidate for the development of antidepressant medications. Its impact on serotonin levels can help alleviate symptoms associated with mood disorders.
Used in Substance Abuse Disorder Treatment:
Additionally, (S)-1-phenyl-2-methoxyethylamine hydrochloride has been investigated for its potential use in the treatment of substance abuse disorders. Its modulatory effects on neurotransmitters could contribute to the development of medications that help individuals recover from addiction and prevent relapse.
Check Digit Verification of cas no
The CAS Registry Mumber 64715-86-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,7,1 and 5 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 64715-86:
(7*6)+(6*4)+(5*7)+(4*1)+(3*5)+(2*8)+(1*6)=142
142 % 10 = 2
So 64715-86-2 is a valid CAS Registry Number.
64715-86-2Relevant academic research and scientific papers
IAP BIR DOMAIN BINDING COMPOUNDS
-
, (2008/06/13)
Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula (I) or (II) or a salt thereof, in which R1, R2, R3, R100, R200, R300, A, A1, BG, Q and Q1 are substituents described herein. Also disclosed is the use of
Aspartyldipeptide derivatives and sweetener compositions containing the same
-
, (2008/06/13)
Aspartyldipeptide compounds of the formula (I) where R1 is alkyl or alkoxymethyl, R2 is phenyl, benzyl, cyclohexyl or cyclohexylmethyl, C* has an (S) configuration when R1 is alkyl and an (R) configuration when R1 is alkoxymethyl and X is a residue of a D-α-amino acid, a DL-α-amino acid or a residue of a cyclic or acyclic α,α-diallylamino acid and the bond between L-Asp and X is an α-bond; and their use as active ingredients in sweetener compositions.
